80
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Formulation and evaluation of an oral melanoma vaccine

, PhD &
Pages 235-252 | Received 10 Jul 2006, Accepted 20 Sep 2006, Published online: 08 Oct 2008

References

  • Bumgarner GW. Evaluation of the microparticle as an adjuvant or coadjuvant in a tumor vaccine [dissertation]. Mercer University, Atlanta (GA) 2001; 171, Available from Mercer University Swilley Library, Atlanta GA: LB2385.B82 2002
  • Campbell A, Bondy SC. Aluminum-induced oxidative events and its relation to inflammation: A role for the metal in Alzheimer's disease. Cell and Molecular Biology 2000; 46: 721–730
  • Eldridge JH, Meubroek JA, Staas JK, Tice TR, Gilley RM. Vaccine-containing biodegradable microparticles specially enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Advances in Experimental Medicine and Biology 1989; 251: 191–202
  • Eriksson K, Quiding-Jarbrink M, Osek J, Moller A, Bjork S, Holmgren J, Czerkinsky C. Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infection and Immunity 1998; 66: 5889–5896
  • Gersten DM, Williams LJ, Moody D, Montague PM, Law LW, Hearing VJ. The intracellular association of B700 and B50 murine melanoma antigens and their role in tumor rejection. International Journal of Cancer 1989; 43: 497–500
  • Gupta RK, Siber GR. Adjuvants for human vaccines–current status, problems and future prospects. Vaccine 1995; 14: 1263–1276
  • He XW, Wang F, Jiang L, Li J, Liu SK, Xiao ZY, Jin XQ, Zhang YN, He Y, Li K, et al. Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. Journal of General Virology 2005; 86: 601–610
  • Hearing VJ, Gersten DM, Marchalonis JJ. Shed proteins in malignant melanoma. Anticancer Research 1981; 1: 313–316
  • Hearing VJ, Gersten DM, Montague PM, Vieira WD, Galetto G, Law LW. Murine melanoma-specific tumor rejection activity elicited by a purified, melanoma-associated antigen. Journal of Immunology 1986; 137: 379–384
  • Huang Y, Fayad R, Smock A, Ullrich AM, Qiao L. Induction of mucosal and systemic immune responses against human carcinoembryonic antigen by an oral vaccine. Cancer Research 2005; 65: 6990–6999
  • Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infection and Immunity 1997; 65: 1387–1394
  • Kuby J. Immunoglobulins: Structure and function. Immunology. 3rd ed, J Kuby. W.H. Freeman and Company, New York 1997; 125–127
  • Le Fevre ME, Joel DD. Novel approaches for oral delivery of macromolecules. Intestinal Toxicology, CM Schiller. Raven Press, New York 1985; 45–56
  • Martin MED, Dewar JB, Newman JFE. Polymerized serum albumin beads possessing slow release properties for use in vaccines. Vaccine 1988; 6: 33–38
  • Poland GA, Murray D, Bonilla-Guerrero R. New vaccine development. British Medical Journal 2002; 324: 1315–1319
  • Quiding M, Nordstrom I, Kilander A, Andersson G, Hanson LA, Holmgren J, Czerkinsky C. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. Journal of Clinical Investigation 1991; 88: 143–148
  • Raychaudhuri S, Rock KL. Fully mobilizing host defense: Building better vaccines. Nature Biotechnology 1998; 16: 1025–1031
  • Roser M, Fischer D, Kissel T. Surface-modified biodegradable albumin nano- and microparticles. II: Effect of surface charges on in vitro phagocytosis and biodistribution in rats. European Journal of Pharmaceutics and Biopharmaceutics 1998; 46: 255–263
  • Singh M, Ugozzoli M, Kazzaz J, Chesko J, Soenawan E, Mannucci D, Titta F, Contorni M, Volpini G, Del Guidice G, et al. A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens. Vaccine 2005; 24: 1680–1686
  • Stertman L, Lundgren E, Sjoholm I. Starch microparticles as a vaccine adjuvant: Only uptake in Peyer's patches decides the profile of the immune response. Vaccine 2006; 17: 3661–3668
  • Tabata Y, Ikada Y. Effects of the size and surface charge of polymer microparticles on their phagocytosis by macrophages. Biomaterials 1988; 9: 356–362
  • Xu X, Azumi N, Skelton HG, Hearing VJ, Gersten DM. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen. European Journal of Cancer 1996; 32A: 168–173

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.